Sort
11,323 grants matching “glioblastoma”
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2017 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2016 · CA
Glioblastoma Genome Project to Locate Molecular Targets
$580,438Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2008 · NS
Enhancing Treatment Response by Leveraging STAT5-OLIG2 signaling in GBM
$580,194Nhan L Tran · Mayo Clinic Arizona · R56 · FY2020 · NS
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action
$579,889Russell O Pieper · University Of California, San Francisco · P01 · FY2015 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis
$579,566Sarah J. Nelson · University Of California, San Francisco · P01 · FY2013 · CA
Enhanced Deuterium Metabolic Imaging (DMI) of Metabolic Reprogramming in Brain Tumors
$579,483Daniel M Spielman · Stanford University · R01 · FY2024 · CA
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
$578,693Xiaonan Li · Baylor College Of Medicine · U01 · FY2016 · CA
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
$578,693Xiaonan Li · Baylor College Of Medicine · U01 · FY2017 · CA
Improving the efficacy of mTOR inhibition
$578,475William A Weiss · University Of California, San Francisco · R01 · FY2022 · CA
Circulating cell-free DNA methylation as an accurate tool for detection and clinical follow-up of glioma
$578,475Houtan Noushmehr · Henry Ford Health System · R01 · FY2025 · CA
Targeting Kif11 to Treat Glioblastoma Invasion and Proliferation
$578,057Steven S Rosenfeld · Mayo Clinic Jacksonville · R01 · FY2020 · NS
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)
$577,848Elaine R Mardis · Washington University · U01 · FY2011 · GM
Targeting SEC61 complex to overcome resistance to immunotherapy in GBM
$577,634Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2025 · CA
Verteporfin as a YAP/TAZ inhibitor for treatment of glioblastoma
$577,469Renee D Read · Emory University · R01 · FY2023 · NS
Temporal analysis of the GBM tumor microenvironment during myeloid cell activating therapy
$577,345Ralph Weissleder · Massachusetts General Hospital · R01 · FY2023 · CA
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
$577,033Alexander V Ljubimov · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Project 2: Molecular and Clinical Inputs Affecting Optimization of Glioma Therapy
$576,371Eric C Holland · Dana-Farber Cancer Inst · U54 · FY2017 · CA
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA
$576,100Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2014 · CA
Treatment of glioblastoma using chain-like nanoparticles
$576,094Efstathios Karathanasis · Case Western Reserve University · U01 · FY2015 · CA
Project 1
$576,031David J Odde · University Of Minnesota · P01 · FY2021 · CA
Angiogenesis-targeting therapy for glioblastoma
$575,734Tracy T Batchelor · Massachusetts General Hospital · R01 · FY2015 · CA
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$575,374Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2022 · NS
Quantitative MRI of Glioblastoma Response
$575,228Jayashree Kalpathy-Cramer · Massachusetts General Hospital · U01 · FY2014 · CA
Interstitial Fluid Flow Regulates Glioma Cell Invasion
$575,131Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R37 · FY2018 · CA